Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GLI2 mRNA | decreases expression | 19150397
|
C014347 |
decitabine |
decitabine results in decreased expression of GLI2 mRNA | decreases expression | 19363521
|
C014347 |
decitabine |
TP53 protein affects the reaction [decitabine results in decreased expression of GLI2 mRNA] | affects reaction|decreases expression | 19363521
|
D004958 |
Estradiol |
Estradiol affects the expression of GLI2 mRNA | affects expression | 14699072
|
C525593 |
JK184 |
JK184 affects the activity of GLI2 protein | affects activity | 19222062
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased expression of GLI2 mRNA | decreases expression | 12057914
|
D008713 |
Methimazole |
Methimazole results in increased expression of GLI2 mRNA | increases expression | 17399805
|
C494474 |
perchlorate |
perchlorate results in increased expression of GLI2 mRNA | increases expression | 17399805
|
D011374 |
Progesterone |
Progesterone affects the expression of GLI2 mRNA | affects expression | 17251523
|
D011441 |
Propylthiouracil |
Propylthiouracil results in increased expression of GLI2 mRNA | increases expression | 17399805
|
D012643 |
Selenium |
Selenium results in increased expression of GLI2 mRNA | increases expression | 19244175
|
D014284 |
Triiodothyronine |
Triiodothyronine results in increased expression of GLI2 mRNA | increases expression | 17403546
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of GLI2 mRNA | increases expression | 16120747 17586704
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of GLI2 mRNA | increases expression | 19101580
|
D014810 |
Vitamin E |
Vitamin E results in increased expression of GLI2 mRNA | increases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.59 | 14514962 15322242 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
8.59 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.98 | 19490988 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
4.09 | 18653653 11850527 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.11 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.46 | 16835633 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.33 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.00 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.62 | 17497229 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.00 | 19460635 15238991 17157402 18558336 18177632 18985861 18940202 18316065 17688650 20603192 18396377 17507914 16609825 19232924 18775368 |
MESH:D001478 |
Basal Cell Nevus Syndrome |
marker/mechanism |
|
| 16936257 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.10 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Propylthiouracil |
9.36 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.36 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.89 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.13 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.13 | 8888407 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.43 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.33 | 15665606 15380490 15845082 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
1.96 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.96 | 17289903 17018787 12948864 16675129 17261762 14630087 19861407 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
1.96 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.96 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.55 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
4.00 | 16050911 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.84 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
marker/mechanism |
|
| 10700170 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
1.77 | 16924424 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
2.61 | 19215824 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.39 | 18850075 18670907 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.77 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.77 | 18566989 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.72 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.21 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.12 | 15668235 8697196 12621046 15340226 16354765 |
MESH:D003092 |
Colitis |
|
Selenium |
3.85 | 17936198 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.34 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.11 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.80 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.80 | 16575769 8888407 17688650 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
3.80 | 19769572 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.68 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.46 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.56 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
6.31 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.31 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
6.31 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.80 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.11 | 1851702 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.80 | 9068938 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.43 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.00 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.84 | 17692515 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.21 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.01 | 11473722 18566989 19148513 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
9.10 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
9.10 | 10568697 9294722 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.48 | 15328337 17637181 15821434 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.23 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.01 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.96 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.63 | 7562514 6426943 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.37 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.15 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.09 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.05 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
3.35 | 14986274 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.53 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.98 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.19 | 18558336 8888407 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
4.06 | 9205823 11852909 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.02 | 20067830 |
MESH:D006042 |
Goiter |
|
perchlorate |
5.36 | 18801409 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.69 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.52 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.66 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
6.66 | 16080930 |
MESH:D006333 |
Heart Failure |
|
Selenium |
3.11 | 17162251 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.43 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.39 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.96 | 15340226 16120746 12621046 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.72 | 16490937 16863852 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.13 | 15709030 |
MESH:D016142 |
Holoprosencephaly |
marker/mechanism |
|
| |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
10.38 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
10.38 | 14716179 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.95 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.14 | 8697196 16354765 15340226 18606429 16959395 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.92 | 18850075 18670907 |
MESH:D006980 |
Hyperthyroidism |
|
Methimazole |
5.68 | 14678291 |
MESH:D007037 |
Hypothyroidism |
|
Methimazole |
12.20 | 18031379 |
MESH:D007037 |
Hypothyroidism |
|
Propylthiouracil |
12.20 | 8137927 18031379 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.47 | 15869954 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
3.24 | 17581917 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
8.53 | 17963957 12878042 17255318 17237260 9205823 |
MESH:D007249 |
Inflammation |
|
Progesterone |
8.53 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.53 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
11.29 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
11.29 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.00 | 16627594 16393666 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.69 | 17255318 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.39 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.21 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
6.21 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
3.94 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
3.02 | 15610895 |
MESH:D007938 |
Leukemia |
|
decitabine |
3.10 | 19235587 18980019 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.06 | 19117987 17236224 18454857 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
4.03 | 19010910 18460780 19387464 17679729 18206229 18704418 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
4.03 | 17596541 16294345 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.56 | 18055864 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.78 | 15821434 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
5.02 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
5.02 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
5.02 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
5.02 | 16169303 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
1.73 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.14 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
3.21 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.36 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
4.08 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.32 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
2.32 | 11062179 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.46 | 19470736 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
10.19 | 11807958 16891317 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
10.19 | 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
10.19 | 15318939 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.58 | 19453300 |
MESH:D008545 |
Melanoma |
|
decitabine |
2.25 | 16505122 17785578 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.81 | 15107826 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.23 | 18803445 18765137 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.38 | 18172295 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.08 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
7.60 | 18608210 19010910 16882708 19157545 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.60 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.06 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.32 | 16810080 |
MESH:D009369 |
Neoplasms |
|
decitabine |
2.73 | 19470736 19116145 17925555 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.81 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.68 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.68 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.16 | 16359493 8888407 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
8.02 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
8.02 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
8.02 | 17393432 16525653 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
2.78 | 19294695 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.35 | 12520081 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.99 | 15087411 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.64 | 11605937 12224865 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.62 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.74 | 11118676 11896295 11399792 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.74 | 20603192 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.80 | 17616702 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.94 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.22 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
3.22 | 15084515 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.64 | 11422049 12752131 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.76 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.90 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
11.17 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
11.17 | 19155313 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.87 | 18045962 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.07 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.77 | 1511512 15475178 14763951 16876388 3137016 11738929 11044598 17978042 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.45 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
marker/mechanism |
|
| 10700170 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.07 | 16192470 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.36 | 15862959 16503802 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.82 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.64 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.56 | 16517955 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.21 | 15821434 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.00 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
7.68 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Propylthiouracil |
7.68 | 15710170 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.78 | 19048282 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.33 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.60 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
2.74 | 19087683 17616700 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.71 | 8888407 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.01 | 17785578 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.69 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.35 | 15886252 |